Qube Research & Technologies LTD Codiak Bio Sciences, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.82 - $3.19 $707 - $2,752
-863 Reduced 7.65%
10,421 $8,000
Q2 2022

Aug 15, 2022
BUY
$2.24 - $6.96 $25,276 - $78,536
11,284 New
11,284 $32,000
Q3 2021

Nov 12, 2021
SELL
$15.58 - $22.88 $180,478 - $265,041
-11,584 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$11.72 - $26.81 $135,764 - $310,567
11,584 New
11,584 $215,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Codiak BioSciences, Inc.

CDAK Quotes by TradingView
  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email